Medical News

RSS

African-Americans less likely to have varus thrust, more likely to have valgus thrust than Caucasians

A recent study determined that African-Americans were less likely to have a varus thrust, but more likely to have valgus thrust than Caucasians. Varus thrust is visualized during gait as the worsening or abrupt onset of varus (bow-legged) alignment as the leg accepts weight, with a return to less varus and more neutral alignment during lift-off of the foot and the swing phase of gait.

3 May 2010

Stimatix reports interim results from artificial sphincter trial for restoring bowel control in people with stoma

Stimatix GI, located in the Misgav Venture Accelerator, has reported encouraging interim results in its animal trials of the AOS-C1000 artificial sphincter, designed to provide stoma patients with a new means of bowel control.

3 May 2010

Sleep problems in children and adolescents with ASDs associated with daytime behaviors: Report

Reports have suggested that sleep problems in children and adolescents with autism spectrum disorders are associated with challenging daytime behaviors.

3 May 2010

Decrease in hospital-wide mortality rates associated with CPOE system: Researchers

Researchers at Lucile Packard Children's Hospital and Stanford University School of Medicine have shown for the first time that a significant decrease in hospital-wide mortality rates can be associated with implementation of a computerized physician order entry system.

3 May 2010

Ensign subsidiary acquires Horizon Home Health and Hospice

The Ensign Group, Inc., announced today that an Ensign subsidiary acquired the operating assets of Horizon Home Health and Hospice, a well-regarded home health and hospice agency based in Meridian, Idaho. The Horizon purchase was effective May 1, 2010.

3 May 2010

Raptor Pharmaceutical presents positive results from Phase 2a trial of DR cysteamine bitartrate for NASH

Raptor Pharmaceutical Corp., announced positive Phase 2a clinical trial results from its pilot study of delayed-release cysteamine bitartrate in 11 adolescent patients with non-alcoholic steatohepatitis, a progressive form of liver disease believed to affect 5% to 11% of the U.S. population. The results were presented at the Digestive Disease Week 2010 conference in New Orleans, LA on May 2, 2010.

3 May 2010

UBC announces acquisition of ABS

United BioSource Corporation today announced the acquisition of Abt Bio-Pharma Solutions, Inc., a Boston, Massachusetts-based provider of health economics and outcomes research, registries and observational studies, and market access solutions to the biopharmaceutical, medical device, and diagnostics industries.

3 May 2010

Researcher finds evidence of how human behavior can influence emergence of infectious disease

After studying the interactions of human and animal populations in Africa, Kathleen Alexander, associate professor of wildlife science in Virginia Tech's College of Natural Resources, found powerful evidence of how human behavior can influence the emergence of infectious disease in humans and animals.

3 May 2010

Integra LifeSciences Holdings reports 7% increase in total revenues for first-quarter 2010

Integra LifeSciences Holdings Corporation today reported its financial results for the first quarter ending March 31, 2010. Total revenues for the first quarter were $172.7 million, reflecting an increase of $11.7 million, or 7%, over the first quarter of 2009. Excluding the impact of currency exchange rates, revenues increased 6% over the first quarter of 2009.

3 May 2010

Inspire Pharmaceuticals reports net loss of $14.8M for first-quarter 2010

Inspire Pharmaceuticals, Inc. announced today financial results for the first quarter ended March 31, 2010, reporting a net loss of $14.8 million or ($0.18) per share.

3 May 2010

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.

3 May 2010

Scientist to receive 2010 March of Dimes Prize in Developmental Biology

The scientist who reprogrammed adult cells into embryonic-like stem cells has been chosen to receive the 2010 March of Dimes Prize in Developmental Biology.

3 May 2010

Extended hepatitis C treatment increases sustained virological response after liver transplant

Extending hepatitis C treatment for liver transplant patients beyond current standards results in high clearance rates of the hepatitis C virus from the blood, and a low relapse rate, according to a study by Henry Ford Hospital.

3 May 2010

McNeil Consumer Healthcare implements voluntary recall of infant and children's liquid products

Working in consultation with the United States Food and Drug Administration, McNeil Consumer Healthcare is implementing a voluntary recall of infant and children's liquid products due to manufacturing deficiencies which may affect quality, purity or potency.

3 May 2010

Protein test to determine response of lung cancer patients to erlotinib

Testing for the presence of specific cancer protein 'fingerprints' in the blood of lung cancer patients may be a useful means of identifying a subgroup whose tumors are more likely to shrink when treated with the drug erlotinib, especially when other testing methods are unavailable, according to new data presented at the 2nd European Lung Cancer Conference in Geneva, Switzerland.

3 May 2010

Some parts of cholesterol testing for children can be performed without fasting: Study

Physicians usually ask children to fast overnight before a cholesterol test. New research shows that this may not always be necessary.

3 May 2010

New classification of depressive subtypes of depression proposed

Lichtenberg and Belmaker propose a new classification of depressive subtypes of depression in the current issue of Psychotherapy and Psychosomatics. They argue that a simple diagnosis is no longer sufficient to guide treatment.

3 May 2010

While global adult mortality rates drop, gaps between countries grow, Lancet study finds

"The global mortality rate for adults [ages 15-59] has fallen by about 1 percent a year for the past 40 years, with women making greater gains than men and huge differences opening up between countries and regions over that period, according to a new study" published online Friday in the journal Lancet, the Washington Post reports, noting the study offers "the most detailed nation-by-nation trends in adult mortality" to date.

3 May 2010

Conservative therapies recommended over routine use of OTC cough/cold products in children

Despite their widespread use by parents and caregivers, over-the-counter cold and cough medicines have carried a warning by the FDA since 2008, and still have the potential to cause serious adverse events in infants and children. Conservative therapies, including nasal suctioning, humidification, and nasal saline, should be recommended over routine use of OTC cough/cold products in infants and children, according to a new commentary published in the May 2010 issue of Otolaryngology - Head and Neck Surgery.

3 May 2010

Scripps Research Institute awarded grant to design assays for exploring potential target for obesity, Type 2 diabetes

The Scripps Research Institute has been awarded a $1.3 million grant by the National Institutes of Health (NIH) to develop a series of tests at its Florida campus to help explore the potential of a protein that has emerged as a highly attractive target for the treatment of obesity and Type 2 diabetes.

3 May 2010

Medical News

African-Americans less likely to have varus thrust, more likely to have valgus thrust than Caucasians

Stimatix reports interim results from artificial sphincter trial for restoring bowel control in people with stoma

Sleep problems in children and adolescents with ASDs associated with daytime behaviors: Report

Decrease in hospital-wide mortality rates associated with CPOE system: Researchers

Ensign subsidiary acquires Horizon Home Health and Hospice

Raptor Pharmaceutical presents positive results from Phase 2a trial of DR cysteamine bitartrate for NASH

UBC announces acquisition of ABS

Researcher finds evidence of how human behavior can influence emergence of infectious disease

Integra LifeSciences Holdings reports 7% increase in total revenues for first-quarter 2010

Inspire Pharmaceuticals reports net loss of $14.8M for first-quarter 2010

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Scientist to receive 2010 March of Dimes Prize in Developmental Biology

Extended hepatitis C treatment increases sustained virological response after liver transplant

McNeil Consumer Healthcare implements voluntary recall of infant and children's liquid products

Protein test to determine response of lung cancer patients to erlotinib

Some parts of cholesterol testing for children can be performed without fasting: Study

New classification of depressive subtypes of depression proposed

While global adult mortality rates drop, gaps between countries grow, Lancet study finds

Conservative therapies recommended over routine use of OTC cough/cold products in children

Scripps Research Institute awarded grant to design assays for exploring potential target for obesity, Type 2 diabetes

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News